Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program

In accordance with section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children?s Health Insurance Program Reauthorization Act of 2015, this funding opportunity will be used for developing, improving, updating or expanding quality measures for use in the
Quality Payment Program under the Merit-Based Incentive Payment System and/or Advanced Alternative Payment Models.

Recognizing the benefits of measure development by external stakeholders with.

Agency - Department of Health and Human Services

The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.

Website Address

http://www.cms.gov




Selected Recipients for this Program


RecipientAmount Start DateEnd Date
American Academy Of Hospice And Palliative Medicine, Inc. $ 1,899,892   2018-09-142021-09-13
Brigham And Women's Hospital, Inc., The $ 1,869,289   2018-09-142021-09-13
American Psychiatric Association $ 1,802,460   2018-09-142021-09-13
Regents Of The University Of California, San Francisco, The $ 1,579,829   2018-09-142021-09-13
Pacific Business Group On Health $ 1,002,381   2018-09-142021-09-13
American Society Of Clinical Pathology $ 674,071   2018-09-142021-09-13
University Of Southern California $ 400,552   2018-09-142020-09-13
$ 0   
$ 0   
$ 0   



Program Accomplishments

Fiscal Year 2016: N/A. Fiscal Year 2017: The program is new. It is anticipated that 30 applications will be received and 5-10 awards will be granted in fiscal year 2018. Fiscal Year 2018: N/A.

Uses and Use Restrictions

Funds are to be used for measure development activities to provide for a fully developed measure suitable for use in the CMS Quality Payment Program.

Funds may be used to secure technical measure development expertise with external (to the recipient) experts.

Funds should be used in accordance with generally accepted measure development principles.

Funds are not to be used to further a recipient?s measure development activities for measures that are not developed in accordance with the recipient?s development plan such that the measure is no longer applicable to the priorities or needs of the Quality Payment Program.

Funds shall not be used to procure a measure developer when that procurement divests the recipient of the accountability, stewardship and functions of measure development for this funding.

Funding may be used to procure measure development expertise from a measure developer so long as the primary funding recipient maintains the accountability, stewardship and functions of measure development for this funding.

Funds shall not be used to build or purchase permanent improvements to technology and resources for measure development (ex.

hardware, software, and infrastructure) that exceeds more than 10% of total costs of the applicant?s proposed budget.

Eligibility Requirements

Applicant Eligibility

Clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities engaged in quality measure development.

For this funding opportunity, the above categories are referenced collectively as entity or entities.

The language, engaged in quality measure development, pertains to each of the above referenced entities. Entities must: 1) demonstrate, or partner with an organization with demonstrated, quality measure development expertise 2) be engaged in quality measure conceptualization, development, or evaluation 3) be involved in developing evidence-based clinical practice guidelines Otherwise eligible entities must not be actively receiving federal funding for quality measure development, implementation, maintenance, or public reporting activities for quality measures.

However, such an entity may be a sub-recipient on one or multiple applications.

Beneficiary Eligibility

Quality Payment Program provides new opportunities to improve care delivery by supporting and rewarding clinicians as they find new ways to engage patients, families, and caregivers and to improve care coordination and population health management. The quality measures in MIPS and APMs serve as the mechanism of measuring the improved care delivery. With this funding opportunity, CMS is engaging eligible entities to develop the quality measures as a way of enhancing the measure portfolio with additional measures for specialties. An enhanced measure portfolio helps to ensure that a higher percentage of providers can use quality measurement to improve their practice. This results in consumers making more informed decisions regarding their healthcare and overall health care quality improvements. The ultimate beneficiaries from this work are providers, consumers, healthcare stakeholders, and anyone interested in quality as the quality measures developed better reflect the complexity and diversity of our healthcare system and improve the quality of healthcare for everyone.

Credentials/Documentation

No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is not applicable.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.

12372.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. N/A

Award Procedures

Successful applicants will receive a Notice of Award (NoA) signed and dated by the CMS Grants Management Officer that will set forth the amount of the award and other pertinent information. The award will also include standard Terms and Conditions, and may also include additional specific cooperative agreement terms and conditions. Potential applicants should be aware that special requirements could apply to cooperative agreement awards based on the particular circumstances of the effort to be supported and/or deficiencies identified in the application by the review panel. The NoA is the legal document issued to notify the awardee that an award has been made and that funds may be requested from the HHS payment system. The NoA will be sent electronically to the Authorized Official and awardee organization as listed.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children?s Health Insurance Program Reauthorization Act of 2015.

Range of Approval/Disapproval Time

Anticipated dates of awards for Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program is approximately 60 days after the application due date.

Appeals

N/A.

Renewals

N/A.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.

Length and Time Phasing of Assistance

The award is available for up to a 3-year project period comprised of 3 separate 12-month budget periods. Funding will be issued each year through a non-competing continuation award based upon a demonstration of progress. Applicants may apply for a 1, 2, or 3 year project period. See the following for information on how assistance is awarded/released: Upon receiving a Notice of Award, recipients will receive money incrementally via, up to, three separate 12-month budget periods (also called non-competing continuation awards). Each year recipients will submit a progress report where they will be evaluated on their completion of the milestones. Funding will be issued each year through a non-competing continuation award based upon a demonstration of progress.

Post Assistance Requirements

Reports

No program reports are required.

The Federal Financial Report (FFR or Standard Form 425) has replaced the SF-269, SF-269A, SF-272, and SF-272A financial reporting forms.

All grantees must utilize the FFR to report cash transaction data, expenditures, and any program income generated.

Grantees must report on a quarterly basis cash transaction data via the Payment Management System (PMS) using the FFR in lieu of completing a SF-272/SF272A.

Failure to submit the report may result in the inability to access funds.

CMS may enlist a third party entity to assist CMS in monitoring the results and outcomes.

The FFR, containing cash transaction data, is due within 30 days after the end of each quarter.

A Quick Reference Guide for completing the FFR in PMS is at: www.dpm.psc.gov/grant_recipient/guides_forms/ffr_quick_reference.aspx.

The CMS Center for Clinical Standards and Quality will take an active and substantial role in the management, implementation, evaluation, and monitoring of the Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program awards.

The activities funded under the cooperative agreement and their resulting recipient responsibilities will be part of performance tracking, measuring, and evaluation responsibilities of CMS.

CMS will examine how the entities that receive funds used the money.

In addition to submitting the quarterly FFR to PMS, Grantees must also provide, on an annual basis, a report to be uploaded into Grant Solutions which includes their expenditures and any program income generated in lieu of completing a Financial Status Report (FSR) (SF269/269A).

Expenditures and any program income generated should only be included on the annually submitted FFR, as well as the final FFR.

Annual hard-copy FFRs should be mailed and received within 30 calendar days of the applicable year end date.

The final FFR should be uploaded in Grants Solutions within 90 calendar days of the project period end date.

Awardees must agree to cooperate with any Federal evaluation of the project and performance results and provide.

The CMS Center for Clinical Standards and Quality will take an active and substantial role in the management, implementation, evaluation, and monitoring of the Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program awards.

The activities funded under the cooperative agreement and their resulting recipient responsibilities will be part of performance tracking, measuring, and evaluation responsibilities of CMS.

CMS will examine how the entities that receive funds used the money.

In addition to submitting the quarterly FFR to PMS, Grantees must also provide, on an annual basis, a report to be uploaded into Grant Solutions which includes their expenditures and any program income generated in lieu of completing a Financial Status Report (FSR) (SF269/269A).

Expenditures and any program income generated should only be included on the annually submitted FFR, as well as the final FFR.

Annual hard-copy FFRs should be mailed and received within 30 calendar days of the applicable year end date.

The final FFR should be uploaded in Grants Solutions within 90 calendar days of the project period end date.

Awardees must agree to cooperate with any Federal evaluation of the project and performance results and provide required monthly, quarterly, semi-annual (every six months), annual and final (at the end of the cooperative agreement period) reports in a form prescribed by CMS.

Reports will be submitted electronically.

These reports will include how cooperative agreement funds were used, describe progress in their quality measure development work, and describe any barriers, delays, and measurable outcomes.

CMS will provide the format for project reporting and technical assistance necessary to complete required report forms.

All awardees will be required to cooperate in providing the necessary information to CMS and/or a CMS contractor for ongoing performance monitoring.

The contractor would assist CMS in developing appropriate monitoring protocols and tracking performance across awardees and providing for rapid cycle evaluation and early detection of performance problems, including coordination between awardees and CMS and its other contractors.

Performance monitoring will include but is not limited to monthly calls with CMS and/or a CMS contractor.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. N/A

Records

Financial records, supporting documents, statistical records, and all other records pertinent to an award shall be retained by the grantee for a period of 3 years from the date of submission of the final SF-425 (FFR) except if any litigation, claim, financial management review, or audit is started before the expiration of the 3-year period, the records shall be retained until all litigation, claims or audit findings involving the records have been resolved and final action taken.

Financial Information

Account Identification

75-0511-0-1-551.

Obigations

(Salaries) FY 16 $0; FY 17 est $10,000,000; and FY 18 est $10,000,000 - N/A.

Range and Average of Financial Assistance

The Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program Cooperative Agreements expect to award 5-10 agreements with a range of $0-$2,000,000 a year for up to 3 years. The expected total funding is $10,000,000 a years for 3 years totaling $30,000,000. This is a new program with no financial assistance awards (dollars) that were made in the past and current fiscal years.

Regulations, Guidelines, and Literature

Section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children?s Health Insurance Program Reauthorization Act of 2015 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards 45 CFR 75, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards (HHS regulation implementing OMB regulation 2 CFR 200)

Information Contacts

Regional or Local Office

None.

Headquarters Office

Wilfred Agbenyikey 7500 Security Boulevard, Woodlawn, Maryland 21244 Email: Wilfred.Agbenyikey@cms.hhs.gov Phone: 410-786-4399

Criteria for Selecting Proposals

Not Applicable.



Social Entrepreneurship
Spotlight



Girls-Aiding Social Business Accelerators To Help Teen Girls Living In Poverty


Girls-Aiding Social Business Accelerators To Help Teen Girls Living In Poverty

In partnership with the Unreasonable Group, the Nike Foundation is set to launch the Girl Effect Accelerator this November to help social entrepreneurs whose business startups focus on helping economically disadvantaged adolescent girls.




Social Services Jobs

  Fundraising & Development Jobs
  Social Services Jobs
  Education Jobs
  Fundraising & Development Jobs
  Human Services Jobs





More Federal Domestic Assistance Programs


Diabetes, Digestive, and Kidney Diseases Extramural Research | Supporting and Maintaining a Surveillance System for Chronic Kidney Disease (CKD) in the United States | Hurricane Education Recovery | Agricultural Market and Economic Research | ACL National Institute on Disability, Independent Living, and Rehabilitation Research |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2019 Copyright Michael Saunders